Houlihan Lokey, Inc.
At today's price, Houlihan Lokey, Inc. (HLI) is priced for +8.9% earnings growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• Houlihan Lokey is a fee-based advisory firm built on three legs, Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory, and its distinctive feature is that the restructuring arm advises ⟦debtors⟧ and creditors when deals dry up, giving it a counter-cyclical hedge most M&A advisors lack. • The central risk is the deal cycle itself: revenue depends on transactions closing, and the firm acknowledges that for unclosed engagements its fees are ⟦generally limited to the fe
Is HLI overvalued? See what's priced in →
523 institutional managers reported holding HLI in 13F filings for the quarter ended 2026-03-31. Together they hold about 80% of the company; the top 10 hold 36%. 63 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 1.7M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (2.7 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
HLI's share count grew 1.4% over the past five years even with $538.85M spent on repurchases. It pays a dividend, and has paid one every year in our records (12 and counting), raised 9 years straight; the current rate is $0.30 a share annually. Cash returned over the past three years: $445.74M in dividends and $252.89M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at HLI over the trailing three years. Absence is a fact about the company, not a signal. 12 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
HLI's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-04 | -0.3% | +7.1% |
| 2023-11-09 | -1.1% | +12.0% |
| 2024-02-09 | +4.1% | -1.4% |
| 2024-05-22 | +1.9% | +6.3% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
HLI's latest 8-K filings: 2026-05-07 (items 2.02, 9.01); 2026-02-25 (items 8.01, 9.01); 2026-01-29 (items 5.02); 2026-01-29 (items 2.02, 9.01); 2025-12-30 (items 1.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.